tiprankstipranks
Advertisement
Advertisement

HK:2396 Stock Latest News

B&K Corp Calls September EGM to Overhaul Share Structure and Governance
Company AnnouncementsB&K Corp Calls September EGM to Overhaul Share Structure and Governance
12d ago
2396
B&K Corp Plans Decade-Long Share Award Scheme to Align Staff and Shareholders
PremiumCompany Announcements
B&K Corp Plans Decade-Long Share Award Scheme to Align Staff and Shareholders
18d ago
2396
B&K Corporation Moves to Fully Circulate 18% of Share Capital as H Shares in Hong Kong
PremiumCompany Announcements
B&K Corporation Moves to Fully Circulate 18% of Share Capital as H Shares in Hong Kong
18d ago
2396
B&K Corporation’s Interim Loss Widens as R&D Spending Surges
PremiumCompany Announcements
B&K Corporation’s Interim Loss Widens as R&D Spending Surges
18d ago
2396
B&K Corporation Sets August Board Meeting to Review Interim Results and Dividend
PremiumCompany Announcements
B&K Corporation Sets August Board Meeting to Review Interim Results and Dividend
28d ago
2396
B&K Corporation Updates Chinese Name, Stock Short Name and Website Without Operational Impact
PremiumCompany AnnouncementsB&K Corporation Updates Chinese Name, Stock Short Name and Website Without Operational Impact
2M ago
2396
B&K Completes Phase II Patient Enrollment for Diabetic Foot Ulcer Drug Pro-101–2
Premium
Company Announcements
B&K Completes Phase II Patient Enrollment for Diabetic Foot Ulcer Drug Pro-101–2
2M ago
2396
B&K Corporation Shareholders Approve All AGM Resolutions, Overhaul Governance and Capital Mandates
Premium
Company Announcements
B&K Corporation Shareholders Approve All AGM Resolutions, Overhaul Governance and Capital Mandates
2M ago
2396
B&K Corporation Calls 2025 AGM to Revamp Governance and Capital Mandates
PremiumCompany Announcements
B&K Corporation Calls 2025 AGM to Revamp Governance and Capital Mandates
3M ago
2396
B&K Corporation Enrolls First Patient in Phase IIIa Trial for Key Burn Treatment
PremiumCompany Announcements
B&K Corporation Enrolls First Patient in Phase IIIa Trial for Key Burn Treatment
4M ago
2396
B&K Corporation to Change Chinese Name to Sharpen Innovative Drug Focus
PremiumCompany Announcements
B&K Corporation to Change Chinese Name to Sharpen Innovative Drug Focus
4M ago
2396
B&K Corporation Moves to Overhaul Governance Structure and Abolish Supervisory Committee
PremiumCompany Announcements
B&K Corporation Moves to Overhaul Governance Structure and Abolish Supervisory Committee
5M ago
2396
B&K Corporation Narrows Loss Amid Higher Cash Reserves and Steady R&D Spend in 2025
PremiumCompany AnnouncementsB&K Corporation Narrows Loss Amid Higher Cash Reserves and Steady R&D Spend in 2025
5M ago
2396
B&K Corporation Sets March Board Meeting to Approve 2025 Results
Premium
Company Announcements
B&K Corporation Sets March Board Meeting to Approve 2025 Results
6M ago
2396
B&K Corporation Wins Strong Shareholder Backing for 2026 Plan and Bonus Payout
Premium
Company Announcements
B&K Corporation Wins Strong Shareholder Backing for 2026 Plan and Bonus Payout
7M ago
2396
B&K Corporation Shakes Up Finance and Governance Leadership Ahead of 2026
PremiumCompany Announcements
B&K Corporation Shakes Up Finance and Governance Leadership Ahead of 2026
7M ago
2396
B&K Corporation Calls 2026 EGM to Approve Bonus, Auditor and Annual Plan
PremiumCompany Announcements
B&K Corporation Calls 2026 EGM to Approve Bonus, Auditor and Annual Plan
7M ago
2396
B&K Corporation to Convene 2026 First EGM, Closes H-Share Register for Voting Eligibility
PremiumCompany Announcements
B&K Corporation to Convene 2026 First EGM, Closes H-Share Register for Voting Eligibility
7M ago
2396
B&K Corporation Ends Stabilization Period With No Over-Allotment Option Exercise
PremiumCompany Announcements
B&K Corporation Ends Stabilization Period With No Over-Allotment Option Exercise
8M ago
2396

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >